135 related articles for article (PubMed ID: 1721407)
1. Effect of FK 506 on experimental liver carcinogenesis.
Shinozuka H; Warty VS; Masuhara M; Murase N; Iwatsuki S
Transplant Proc; 1991 Dec; 23(6):3197-9. PubMed ID: 1721407
[No Abstract] [Full Text] [Related]
2. Expression of a 65-kDa tumor-associated protein and persistence of altered hepatic foci.
Hanausek M; Sherman U; Adams AK
Prog Clin Biol Res; 1991; 369():91-103. PubMed ID: 1946546
[No Abstract] [Full Text] [Related]
3. Lack of carcinogenicity of daminozide, alone or in combination with its contaminant 1,1-dimethylhydrazine, in a medium-term bioassay.
Cabral R; Hakoi K; Hoshiya T; Hasegawa R; Ito N
Teratog Carcinog Mutagen; 1995-1996; 15(6):307-12. PubMed ID: 8732881
[TBL] [Abstract][Full Text] [Related]
4. Lack of potential of low dose N-nitrosodimethylamine to induce preneoplastic lesions, glutathione S-transferase placental form-positive foci, in rat liver.
Fukushima S; Wanibuchi H; Morimura K; Nakae D; Tsuda H; Imaida K; Shirai T; Tatematsu M; Tsukamoto T; Hirose M; Furukawa F
Cancer Lett; 2005 May; 222(1):11-5. PubMed ID: 15837536
[TBL] [Abstract][Full Text] [Related]
5. [Evolution of hyperplastic foci in the rat liver induced by diethylnitrosamine].
Gel'shteĭn VI; Chipysheva TA; Bannikov GA
Eksp Onkol; 1984; 6(1):17-22. PubMed ID: 6209086
[TBL] [Abstract][Full Text] [Related]
6. Reversible alteration in the expression of the gap junctional protein connexin 32 during tumor promotion in rat liver and its role during cell proliferation.
Neveu MJ; Hully JR; Paul DL; Pitot HC
Cancer Commun; 1990; 2(1):21-31. PubMed ID: 1973356
[TBL] [Abstract][Full Text] [Related]
7. Effect of S-adenosyl-L-methionine on the development of preneoplastic foci and the activity of some carbohydrate metabolizing enzymes in the liver, during experimental hepatocarcinogenesis.
Gerbracht U; Eigenbrodt E; Simile MM; Pascale RM; Gaspa L; Daino L; Seddaiu MA; De Miglio MR; Nufris A; Feo F
Anticancer Res; 1993; 13(6A):1965-72. PubMed ID: 8297102
[TBL] [Abstract][Full Text] [Related]
8. Promoting potential of a Jamaica quassia extract in a rat medium-term hepatocarcinogenesis bioassay.
Woo GH; Shibutani M; Inoue K; Fujimoto H; Takahashi M; Lee KY; Hirose M
Food Chem Toxicol; 2007 Jul; 45(7):1160-4. PubMed ID: 17306917
[TBL] [Abstract][Full Text] [Related]
9. Concordance of thresholds for carcinogenicity of N-nitrosodiethylamine.
Waddell WJ; Fukushima S; Williams GM
Arch Toxicol; 2006 Jun; 80(6):305-9. PubMed ID: 16308687
[TBL] [Abstract][Full Text] [Related]
10. The role of somatic mutations and cell replication kinetics in quantitative cancer risk assessment.
Moolgavkar SH; Luebeck EG
Prog Clin Biol Res; 1991; 369():469-79. PubMed ID: 1835095
[No Abstract] [Full Text] [Related]
11. Modifying effects of various chemicals on preneoplastic and neoplastic lesion development in a wide-spectrum organ carcinogenesis model using F344 rats.
Fukushima S; Hagiwara A; Hirose M; Yamaguchi S; Tiwawech D; Ito N
Jpn J Cancer Res; 1991 Jun; 82(6):642-9. PubMed ID: 1906850
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the development of rat liver preneoplastic lesions by verapamil and dexverapamil.
Ghia M; Mereto E; Cavanna M; Brambilla G
Anticancer Res; 1996; 16(4A):1739-41. PubMed ID: 8712693
[TBL] [Abstract][Full Text] [Related]
13. Quantitative stereological analysis of the effects of age and sex on multistage hepatocarcinogenesis in the rat by use of four cytochemical markers.
Xu YH; Campbell HA; Sattler GL; Hendrich S; Maronpot R; Sato K; Pitot HC
Cancer Res; 1990 Feb; 50(3):472-9. PubMed ID: 1967547
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of rat liver cell foci development by combined treatment with heterocyclic amines at low doses.
Ito N; Hasegawa R; Asakawa E; Hirose M; Imaida K; Hagiwara A
Princess Takamatsu Symp; 1995; 23():251-9. PubMed ID: 8844816
[TBL] [Abstract][Full Text] [Related]
15. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis by a simple phenolic acid protocatechuic acid in rats.
Tanaka T; Kojima T; Kawamori T; Yoshimi N; Mori H
Cancer Res; 1993 Jun; 53(12):2775-9. PubMed ID: 8504418
[TBL] [Abstract][Full Text] [Related]
17. Medium-term carcinogenicity bioassay.
Della Porta G
Jpn J Cancer Res; 1992 Aug; 83(8):inside front cover. PubMed ID: 1399815
[No Abstract] [Full Text] [Related]
18. A physiologically based pharmacodynamic analysis of hepatic foci within a medium-term liver bioassay using pentachlorobenzene as a promoter and diethylnitrosamine as an initiator.
Thomas RS; Conolly RB; Gustafson DL; Long ME; Benjamin SA; Yang RS
Toxicol Appl Pharmacol; 2000 Jul; 166(2):128-37. PubMed ID: 10896854
[TBL] [Abstract][Full Text] [Related]
19. Enhancement by organosulfur compounds from garlic and onions of diethylnitrosamine-induced glutathione S-transferase positive foci in the rat liver.
Takada N; Matsuda T; Otoshi T; Yano Y; Otani S; Hasegawa T; Nakae D; Konishi Y; Fukushima S
Cancer Res; 1994 Jun; 54(11):2895-9. PubMed ID: 8187074
[TBL] [Abstract][Full Text] [Related]
20. The effect of dieldrin and phenobarbital on preneoplastic hepatic lesion growth in male F344 rat and B6C3F1 mouse.
Kolaja KL; Stevenson DE; Walborg EF; Klaunig JE
Prog Clin Biol Res; 1995; 391():409-23. PubMed ID: 8532733
[No Abstract] [Full Text] [Related]
[Next] [New Search]
